Background: Cidofovir (CDV) is an acyclic nucleoside phosphonate that exhibits a potent antiviral activity against several DNA viruses. In previous studies, CDV has been shown to significantly reduce the clinical severity and the viral shedding in primary caprine herpesvirus type-1 (CpHV-1) infection in goats. CpHV-1 is an alpha-herpesvirus showing many biological similarities with human herpesvirus type-2 (HHV-2); therefore, studies conducted on the CpHV-1 goat model could provide useful information on the pathogenesis, therapy and prevention of HHV-2 infection in humans. Methods: CDV was administered to goats infected by vaginal route with CpHV-1. Real-time PCR was carried out on sacral ganglia from CpHV-1-infected goats to detect and quantify latent CpHV-1 DNA. Results: Viral DNA was variably found in all five pairs of sacral ganglia, with a more frequent involvement of the third and fourth pair. In CDV-treated goats, the amount of CpHV-1 DNA did not appear to be related either to the severity of the clinical signs or the titre of the virus shed during primary CpHV-1 infection. Conclusions: CDV failed to prevent CpHV-1 latency. Thus, vaginal CDV administration during primary herpesvirus infection, although providing immediate clinical benefits to the host might not influence the establishment of latency and, consequently, the rate of recurrent infections.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats|
|Data di pubblicazione:||2010|
|Citazione:||Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats / Camero, M; Crescenzo, G; Marinaro, M; Tarsitano, E; Bellacicco, Al; Armenise, C; Buonavoglia, C; Tempesta, M. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - 15(2010), pp. 785-788.|
|Appare nelle tipologie:||1.1 Articolo in rivista|